954 filings
Page 24 of 48
S-3/A
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration (amended)
25 Nov 16
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
23 Nov 16
Correspondence with SEC
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
23 Nov 16
Correspondence with SEC
12:00am
UPLOAD
ARWR
Arrowhead Pharmaceuticals Inc.
18 Nov 16
Letter from SEC
12:00am
UPLOAD
ARWR
Arrowhead Pharmaceuticals Inc.
15 Nov 16
Letter from SEC
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
10 Nov 16
Arrowhead Pharmaceuticals Provides Update on Heparc-2004 Study
12:00am
S-3
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration
28 Oct 16
12:00am
S-3
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration
28 Oct 16
12:00am
4
ARWR
Arrowhead Pharmaceuticals Inc.
18 Oct 16
ARROWHEAD PHARMACEUTICALS / DOUGLAS B GIVEN ownership change
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
29 Sep 16
Amgen and Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
29 Sep 16
Regulation FD Disclosure
12:00am
424B3
ARWR
Arrowhead Pharmaceuticals Inc.
29 Sep 16
Prospectus supplement
12:00am
EFFECT
ARWR
Arrowhead Pharmaceuticals Inc.
22 Sep 16
Notice of effectiveness
12:00am
CORRESP
ARWR
Arrowhead Pharmaceuticals Inc.
20 Sep 16
Correspondence with SEC
12:00am
UPLOAD
ARWR
Arrowhead Pharmaceuticals Inc.
19 Sep 16
Letter from SEC
12:00am
S-3
ARWR
Arrowhead Pharmaceuticals Inc.
Shelf registration
2 Sep 16
12:00am
4/A
ARWR
Arrowhead Pharmaceuticals Inc.
26 Aug 16
ARROWHEAD PHARMACEUTICALS / Kenneth Allen Myszkowski ownership change
12:00am
4
ARWR
Arrowhead Pharmaceuticals Inc.
24 Aug 16
ARROWHEAD PHARMACEUTICALS / Kenneth Allen Myszkowski ownership change
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
10 Aug 16
Arrowhead Pharmaceuticals Prices $45 Million Private Offering
12:00am
8-K
ARWR
Arrowhead Pharmaceuticals Inc.
9 Aug 16
Arrowhead Reports Fiscal 2016 Third Quarter Results
12:00am